MC2050A1 - Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication - Google Patents
Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabricationInfo
- Publication number
- MC2050A1 MC2050A1 MC892067A MC2067A MC2050A1 MC 2050 A1 MC2050 A1 MC 2050A1 MC 892067 A MC892067 A MC 892067A MC 2067 A MC2067 A MC 2067A MC 2050 A1 MC2050 A1 MC 2050A1
- Authority
- MC
- Monaco
- Prior art keywords
- benzopyrannol
- derivatives
- manufacture
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23009488A | 1988-08-09 | 1988-08-09 | |
US07/367,082 US5015661A (en) | 1988-08-09 | 1989-06-16 | Chromanes and their pharmaceutical compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MC2050A1 true MC2050A1 (fr) | 1990-07-17 |
Family
ID=26923917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC892067A MC2050A1 (fr) | 1988-08-09 | 1989-08-07 | Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication |
Country Status (13)
Country | Link |
---|---|
US (1) | US5015661A (xx) |
EP (1) | EP0354508A3 (xx) |
JP (1) | JPH0283379A (xx) |
KR (1) | KR900003175A (xx) |
AU (1) | AU616039B2 (xx) |
DK (1) | DK389089A (xx) |
HU (1) | HU206204B (xx) |
IL (1) | IL91245A0 (xx) |
MC (1) | MC2050A1 (xx) |
NO (1) | NO172643C (xx) |
NZ (1) | NZ230233A (xx) |
PH (1) | PH27235A (xx) |
PT (1) | PT91400A (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1305480C (en) * | 1987-03-20 | 1992-07-21 | Roshantha A.S. Chandraratna | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5149703A (en) * | 1991-09-06 | 1992-09-22 | Merck Frosst Canada, Inc. | Quinoline-substituted chromans and related compounds as leukotriene antagonists |
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
KR960701033A (ko) * | 1993-12-08 | 1996-02-24 | 그레그 씨.브라운 | 효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents) |
US5747528A (en) * | 1996-02-21 | 1998-05-05 | Warner-Lambert Company | Chroman derivatives as anti-oxidants |
ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
US7470798B2 (en) * | 2003-09-19 | 2008-12-30 | Edison Pharmaceuticals, Inc. | 7,8-bicycloalkyl-chroman derivatives |
JP2008523145A (ja) | 2004-12-13 | 2008-07-03 | イーライ リリー アンド カンパニー | リポキシゲナーゼ阻害剤としてのスピロ誘導体 |
BRPI0520097A2 (pt) | 2005-02-25 | 2009-08-25 | Lilly Co Eli | composto ou estereoisÈmeros únicos, misturas de estereoisÈmeros, ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4681890A (en) * | 1984-10-30 | 1987-07-21 | Kuraray Co., Ltd. | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same |
DE3484473D1 (de) * | 1984-12-06 | 1991-05-23 | Kuraray Co | Chroman-verbindungen und deren herstellung. |
JPS61148173A (ja) * | 1984-12-20 | 1986-07-05 | Kuraray Co Ltd | 新規なアミン及びその塩 |
DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
JPS61204122A (ja) * | 1985-03-07 | 1986-09-10 | Kuraray Co Ltd | 肝臓疾患治療剤 |
JPS61210030A (ja) * | 1985-03-13 | 1986-09-18 | Agency Of Ind Science & Technol | 抗腫瘍剤 |
JPS61267571A (ja) * | 1985-05-20 | 1986-11-27 | Kuraray Co Ltd | 2−(4−クロルフエノキシ)−2−メチルプロピオン酸エステル及びこれを有効成分とする血中脂質低下剤 |
JPS61267570A (ja) * | 1985-05-20 | 1986-11-27 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びこれを有効成分とする利胆剤 |
JPS62132879A (ja) * | 1985-12-05 | 1987-06-16 | Kuraray Co Ltd | 3,4−ジヒドロ−2h−ベンゾピラン誘導体類及びこれを有効成分とする抗アレルギ−剤 |
US4752646A (en) * | 1986-01-23 | 1988-06-21 | Hoffmann-La Roche Inc. | 2-halochromans |
US4824971A (en) * | 1986-01-23 | 1989-04-25 | Hoffman-La Roche Inc. | 2-allylchromans |
WO1987005020A1 (en) * | 1986-02-21 | 1987-08-27 | Kuraray Co., Ltd. | 3,4-dihydro-2h-benzopyran derivatives and their medicinal use |
US4879395A (en) * | 1987-03-27 | 1989-11-07 | Hoffmann-La Roche Inc. | Vitamin E intermediate |
US4914217A (en) * | 1987-12-18 | 1990-04-03 | Hoffmann-La Roche Inc. | Asymmetric synthesis of natural vitamin E |
US4831185A (en) * | 1987-12-18 | 1989-05-16 | Hoffmann-La Roche Inc. | Asymmetric synthesis of natural vitamin E |
-
1989
- 1989-06-16 US US07/367,082 patent/US5015661A/en not_active Expired - Fee Related
- 1989-08-07 NZ NZ230233A patent/NZ230233A/en unknown
- 1989-08-07 HU HU893980A patent/HU206204B/hu not_active IP Right Cessation
- 1989-08-07 MC MC892067A patent/MC2050A1/xx unknown
- 1989-08-07 EP EP19890114523 patent/EP0354508A3/de not_active Withdrawn
- 1989-08-08 NO NO893198A patent/NO172643C/no unknown
- 1989-08-08 KR KR1019890011280A patent/KR900003175A/ko not_active Application Discontinuation
- 1989-08-08 AU AU39418/89A patent/AU616039B2/en not_active Ceased
- 1989-08-08 PH PH39069A patent/PH27235A/en unknown
- 1989-08-08 IL IL91245A patent/IL91245A0/xx unknown
- 1989-08-08 PT PT198991400A patent/PT91400A/pt unknown
- 1989-08-08 DK DK389089A patent/DK389089A/da not_active Application Discontinuation
- 1989-08-09 JP JP1204905A patent/JPH0283379A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0283379A (ja) | 1990-03-23 |
NO893198L (no) | 1990-02-12 |
NO172643B (no) | 1993-05-10 |
PT91400A (pt) | 1990-03-08 |
HUT52493A (en) | 1990-07-28 |
DK389089D0 (da) | 1989-08-08 |
AU3941889A (en) | 1990-02-15 |
AU616039B2 (en) | 1991-10-17 |
DK389089A (da) | 1990-02-10 |
IL91245A0 (en) | 1990-03-19 |
EP0354508A3 (de) | 1991-03-27 |
PH27235A (en) | 1993-05-04 |
HU206204B (en) | 1992-09-28 |
EP0354508A2 (de) | 1990-02-14 |
JPH0579072B2 (xx) | 1993-11-01 |
NZ230233A (en) | 1992-03-26 |
US5015661A (en) | 1991-05-14 |
KR900003175A (ko) | 1990-03-23 |
NO172643C (no) | 1993-08-18 |
NO893198D0 (no) | 1989-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2598706B1 (fr) | Derives de tetrahydronaphtalene, compositions pharmaceutiques les contenant et procede de preparation | |
FR2466248B1 (fr) | Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant | |
PT78340B (fr) | Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant | |
PT85279A (fr) | Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant | |
PT77488B (fr) | Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant | |
PT81310A (fr) | Procede de preparation de derives de piperidine et de compositions pharmaceutiques les contenant | |
PT80921A (fr) | Procede de preparation de derives d'acylaminomethyl-3-imidazo<1,2-a>pyridines et de compositions pharmaceutiques les contenant | |
FR2636628B1 (fr) | Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant | |
PT83355A (fr) | Procede de preparation de derives de benzimidazole et de compositions pharmaceutiques les contenant | |
PT83896A (fr) | Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant | |
MC2050A1 (fr) | Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication | |
PT83593A (fr) | Procede de preparation de 7-acyl-benzoxazinones et leurs derives et de compositions pharmaceutiques les contenant | |
PT79365B (fr) | Procede de preparation de derives d'imidazoline et de compositions pharmaceutiques les contenant | |
PT74651B (fr) | Procede de preparation de derives de pyridine et de compositions pharmaceutiques les contenant | |
PT82364A (fr) | Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant | |
FR2582835B1 (fr) | Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant | |
FR2571369B1 (fr) | Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant | |
FR2563519B1 (fr) | Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2615188B1 (fr) | Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant | |
PT77751B (fr) | Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant | |
PT75868B (fr) | Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant | |
IT8103423A0 (it) | Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono | |
PT78272A (fr) | Procede de preparation de derives d'(indenyl-2)-2 imidazole et de compositions pharmaceutiques les contenant | |
FR2649981B1 (fr) | Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant | |
PT78428B (fr) | Procede de preparation de diphenylazomethines et de compositi- ons pharmaceutiques les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
YP | Annual fee paid |